TOREMIFENE vs TORIPALIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TOREMIFENE vs TORIPALIMAB: Safety Overview
| Metric | TOREMIFENE | TORIPALIMAB |
|---|---|---|
| Total FAERS Reports | 245 | 1,344 |
| Deaths Reported | 16 | 65 |
| Death Rate | 6.5% | 4.8% |
| Hospitalizations | 92 | 823 |
| Average Patient Age | 61.7 yrs | 58.0 yrs |
| % Female Patients | 95.0% | 24.9% |
| FDA Approval Date | Aug 18, 2020 | N/A |
| Manufacturer | Kyowa Kirin, Inc. | Coherus Oncology, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |